Hematopoietic cytokines as tumor markers

References

1 Bence Jones H. Papers on chemical pathology – lecture III. Lancet 1847; 2:88–92.10.1016/S0140-6736(02)86528-XSearch in Google Scholar

2 Whicher JT, Banks RE. Cytokines as tumour markers. Scand J Clin Lab Invest 1995; 55:122–44.10.3109/00365519509090576Search in Google Scholar

3 Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage 2000; 20:214–32.10.1016/S0885-3924(00)00199-8Search in Google Scholar

4 Cohen S, Bigazzi PE, Yoshida T. Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 1974; 12:150–9.10.1016/0008-8749(74)90066-5Search in Google Scholar

5 Berdel WE, Danhauser RS, Oberberg D, Zafferani M. Effects of hematopoietic growth factors on malignant nonhematopoietic cells. Semin Oncol 1992; 19:41–5.Search in Google Scholar

6 Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, et al. Human granulocyte colony-stimulating factor: biological activities and receptor characterization on hematopoietic cells and small cell lung cancer lines. Blood 1990; 75:851–7.10.1182/blood.V75.4.851.851Search in Google Scholar

7 Miyagawa K, Chiba S, Shibuya K, Piao YK, Matsuki S, Yokota J, et al. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol 1990; 143:483–7.10.1002/jcp.1041430312Search in Google Scholar PubMed

8 Turner AM, Zsebo KM, Martin F. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80:374–80.10.1182/blood.V80.2.374.374Search in Google Scholar

9 Tani K, Ozawa K, Ogura H, Shimane M., Tsuruta T, Yokota J, et al. Expression of granulocyte and granulocyte-macrophage colony stimulating factors by human non-hematopoietic tumor cells. Growth Factors 1990; 3:325–31.10.3109/08977199009003675Search in Google Scholar PubMed

10 Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 1999; 79:40–6.10.1038/sj.bjc.6690009Search in Google Scholar PubMed PubMed Central

11 Suzuki M, Ohwada M, Sato I. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology 1995; 52:128–33.10.1159/000227443Search in Google Scholar PubMed

12 McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, et al. Circulating macrophage colony-stimulating factor as a marker of tumor progression. E Cytokine Network 2002; 13:121–7.Search in Google Scholar

13 Smith MA, Court EL, Smith JG. Stem cell factor: laboratory and clinical aspects. Blood Rev 2001; 15:191–7.10.1054/blre.2001.0167Search in Google Scholar

14 Glaspy J. Clinical applications of stem cell factor. Curr Opin Hemat 1996; 3:223–9.10.1097/00062752-199603030-00010Search in Google Scholar

15 Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 1991; 78:961–6.10.1182/blood.V78.4.961.961Search in Google Scholar

16 Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A. Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 1992; 52:713–7.10.1002/ijc.2910520508Search in Google Scholar

17 Rygaard K, Nakamura T, Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor in SCLC cell lines and xenografts. Br J Cancer 1993; 67:37–46.10.1038/bjc.1993.7Search in Google Scholar

18 Cohen PS, Chan JP, Lipunskaya M, Biedler JL, Seeger RC. Expression of stem cell factor and c-kit in human neuroblastoma. Blood 1994; 84:3465–72.10.1182/blood.V84.10.3465.3465Search in Google Scholar

19 Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 1994; 54:3049–53.Search in Google Scholar

20 Savarese DM, Valiński H, Quesenberry P, Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 1998; 34:80–91.10.1002/(SICI)1097-0045(19980201)34:2<80::AID-PROS2>3.0.CO;2-NSearch in Google Scholar

21 Strohmeyer T, Reese D, Press M. Expression of c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. 1995;153:511–5.10.1097/00005392-199502000-00073Search in Google Scholar

22 Toyota M, Hinoda Y, Takaoka A, Makiguchi Y, Takahashi T, Iton F, et al. Expression of c-kit and kit ligand in human colon carcinoma cells. Tumor Biol 1993; 14:295–302.10.1159/000217842Search in Google Scholar

23 Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, et al. Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 1995; 6:1111–8.Search in Google Scholar

24 Hassan S, Kinoshita Y, Kawanami Ch, Kishi K, Matsushima Y, Ohashi A, et al. Expression of proto-oncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci 1998; 43:8–14.10.1023/A:1018851415704Search in Google Scholar

25 Mroczko B, Szmitkowski M, Niklinski J. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer. Clin Chem Lab Med 1999; 37:959–62.10.1515/CCLM.1999.141Search in Google Scholar

26 Mroczko B, Szmitkowski M, Okulczyk B. Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 2003; 41:646–51.10.1515/CCLM.2003.098Search in Google Scholar

27 Hsu SM, Hsu PL. Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed Pharmacother 1994; 48:433–44.10.1016/0753-3322(94)90004-3Search in Google Scholar

28 Nachbaur D, Denz H, Zwierzina H, Schmalzl F, Huber H. Stimulation of colony formation of various human carcinoma cell lines by rhGM-CSF and rhIL-3. Cancer Lett 1990; 50:197–201.10.1016/0304-3835(90)90265-YSearch in Google Scholar

29 Berdel WE, Danhauser-Riedl S, Stienhauser G. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989; 73:80–3.10.1182/blood.V73.1.80.80Search in Google Scholar

30 Nemunaitis J. A comparative review of colony-stimulating factors. Drugs 1997; 54:709–29.10.2165/00003495-199754050-00004Search in Google Scholar PubMed

31 Dame JB, Chegini N, Christensen RD, Juul SE. The effect of interleukin-1β and tumor necrosis factor-α (TNF-α) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells. Eur Cytokine Network 2002; 13:128–33.Search in Google Scholar

32 Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, et al. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989; 73:1033–7.10.1182/blood.V73.4.1033.1033Search in Google Scholar

33 Baba M, Hasegawa H, Nakayabu M. Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol 1995; 49:207–16.10.1002/ajh.2830490306Search in Google Scholar PubMed

34 Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 1996; 16:557–64.Search in Google Scholar

35 Dedhar S, Gaboury L, Galloway P, Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhematopoietic origin. Proc Natl Acad Sci USA 1988; 85:9253–7.10.1073/pnas.85.23.9253Search in Google Scholar PubMed PubMed Central

36 Mizuno K, Sone S, Orino E. Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation. Jpn J Cancer 1994; 85:179–86.10.1111/j.1349-7006.1994.tb02080.xSearch in Google Scholar PubMed PubMed Central

37 Armstrong CA, Tara DC, Hart CE, Kock A, Luger TA, Ansel JC. Heterogeneity of cytokine production by human malignant melanoma cells. Exp Dermatol 1992; 1:37–45.10.1111/j.1600-0625.1992.tb00070.xSearch in Google Scholar

38 Trutmann M, Terracciano L, Noppen C, Kloth J, Kaspar M, Peterli R, et al. GM-CSF gene expression and protein production in human colorectal cell lines and clinical tumor specimens. Int J Cancer 1998; 77:378–85.10.1002/(SICI)1097-0215(19980729)77:3<378::AID-IJC12>3.0.CO;2-4Search in Google Scholar

39 Kohn EC, Hollister GH, Dipersio JD, Wahl S, Liotta LA, Schiffman E. Granulocyte-macrophage colony-stimulating factor induces melanoma-cell migration. Int J Cancer 1993; 53:968–72.10.1002/ijc.2910530618Search in Google Scholar

40 Singh RK, Gutman M, Radinsky R. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J Interferon Cytokine Res 1995; 15:81–7.10.1089/jir.1995.15.81Search in Google Scholar

41 Sabourin CL, Wang QS, Mallery SR, Nicholson R, Gopalakrishnan R, Lang JS, et al. Analysis of cytokine gene expression in squamous cell carcinoma of the head and neck. Int J Oncol 1996; 8:49–56.10.3892/ijo.8.1.49Search in Google Scholar

42 Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89:7708–12.10.1073/pnas.89.16.7708Search in Google Scholar

43 Hill AD, Redmond HP, Austin OM, Grace PA, Bouchier-Hayes D. Granulocyte macrophage colony-stimulating factor inhibits tumour growth. Br J Cancer 1993; 80:1543–6.Search in Google Scholar

44 Young MR, Young ME, Wright MA. Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors. Exp Hematol 1990; 18:806–11.Search in Google Scholar

45 Young MR, Lozano Y, Coogan M. Stimulation of the metastasis properties of Lewis-lung-carcinoma cells by autologous granulocyte macrophage colony-stimulating factor. Int J Cancer 1992; 50:628–34.10.1002/ijc.2910500424Search in Google Scholar

46 Takeda K, Hatakeyama K, Tsuchiya Y. A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer 1991; 47:413–20.10.1002/ijc.2910470318Search in Google Scholar

47 Mroczko B, Szmitkowski M, Okulczyk B, Piotrowski Z. Granulocyte-macrophage colony-stimulating factor in patients with colorectal cancer. Folia Histochem Cytobiol 2001; 39(Suppl 2):110–1.10.1515/CCLM.2001.059Search in Google Scholar

48 Sawyers CL, Golde DM, Quan S. Production of granulocyte-macrophage colony stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. Cancer 1992; 69:1342–6.10.1002/1097-0142(19920315)69:6<1342::AID-CNCR2820690607>3.0.CO;2-USearch in Google Scholar

49 Screenan C, Osiovich H. Myeloid colony-stimulating factors. Arch Pediatr Adolesc 1999; 153:984–8.10.1001/archpedi.153.9.984Search in Google Scholar

50 Baba M, Kaito M, Hasegawa H, Nakayabu M, Yoshida Y, Uda Y. Establishment and characterization of a new human thyroid anaplastic cancer cell line that produces human colony-stimulating factor. Mie Med J 1991; 41:155–62.Search in Google Scholar

51 Furihata M, Sonobe H, Ohtsuki Y, Enzan H, Tokuoka H, Nakanuma Y. An immunohistochemical study on a case of granulocyte colony-stimulating factor producing gall-bladder carcinoma. Pathol Int 1999; 49:1010–3.10.1046/j.1440-1827.1999.00970.xSearch in Google Scholar

52 Hirasawa K, Kitamura T, Oka T, Matsushita H. Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein. J Urol 2002; 167:2130–6.10.1016/S0022-5347(05)65104-XSearch in Google Scholar

53 Uematsu T, Tsuchie K, Ukai K, Kimoto E, Funakawa T, Mizuno R. Granulocyte colony-stimulating factor produced by pancreatic carcinoma. Int J Pancreat 1996; 19:135–9.10.1007/BF02805227Search in Google Scholar

54 Sugimoto M, Kajimura M, Hanai H, Shirai N, Tanioka F, Kaneko E. G-CSF-producing gastric anaplastic large cell lymphoma complicating esophageal cancer. Dig Dis Sci 1999; 44:2035–8.10.1023/A:1026674402695Search in Google Scholar

55 Uemura Y, Nakata H, Kobayashi M, Harada R, Asahi Y, Taguchi H. Regulation of granulocyte colony-stimulating factor and parathyroid hormone-related protein production in lung carcinoma cell line OKa-C-1. Jpn J Cancer Res 2000; 91:911–7.10.1111/j.1349-7006.2000.tb01034.xSearch in Google Scholar

56 Logan TF, Gooding W, Kirkwood JM, Shadduck RK. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer. Exp Hematol 1996; 24:49–53.Search in Google Scholar

57 Tachibana M, Miyakawa A, Tazaki H. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995; 55:34–8.Search in Google Scholar

58 Mroczko B, Szmitkowski M, Okulczyk B. Granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 2002; 40:351–5.10.1515/CCLM.2002.056Search in Google Scholar

59 Price LK, Choi HU, Rosenberg L, Stanley ER. The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J Biol Chem 1992; 267:2190–9.10.1016/S0021-9258(18)45861-9Search in Google Scholar

60 Rallidis L, Thomaidis KP, Zolindaki MG, Velissaridou AH, Papasteriadis EG. Elevated concentrations of macrophage colony stimulating factor predict worse in-hospital prognosis in unstable angina. Heart 2001; 86:92–8.10.1136/heart.86.1.92Search in Google Scholar PubMed PubMed Central

61 Roth P, Stanley ER. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 1992; 181:141–67.10.1007/978-3-642-77377-8_5Search in Google Scholar PubMed

62 Kacinski BM, Chambers SK, Stanley ER, Carter D, Tseng P, Scata KA, et al. The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumour marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Physics 1990; 19:619–26.10.1016/0360-3016(90)90488-6Search in Google Scholar

63 Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI, et al. Circulating levels of CSF-1 (M-CSF), a lymphohematopoietic cytokine, may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Physics 1989; 17:159–64.10.1016/0360-3016(89)90383-0Search in Google Scholar

64 Scholl SM, Lidereau R, Rochefordiere A, Cohen-Solal Le-Nir C, Mosseri V, Nogues C, et al. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. Breast Cancer Res Treat 1996; 39:275–83.10.1007/BF01806155Search in Google Scholar PubMed

65 Hamilton JA, Whitty GA, Stanton H, Meager A. Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1 or tumor necrosis factor-alpha. J Leukoc Biol 1993; 53:707–14.10.1002/jlb.53.6.707Search in Google Scholar PubMed

66 Yee LS, Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 2000; 20:4379–84.Search in Google Scholar

67 Chambers SK, Wang Y, Gertz RE, Kacinski BM. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 1995; 55:1578–85.Search in Google Scholar

68 Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J Surg Res 2001; 100:18–24.10.1006/jsre.2001.6204Search in Google Scholar PubMed